Related Experiment Video

Updated: Jun 19, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Current options for systemic therapy in mesothelioma

David M Jackman1

  • 1Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. djackman@partners.org

Seminars in Thoracic and Cardiovascular Surgery
|October 14, 2009
PubMed

Insights

Systemic therapy for mesothelioma is limited. The combination of cisplatin and pemetrexed is the only regimen proven effective in a phase III trial, while targeted therapies are under investigation.

Area of Science:

  • Medical Oncology
  • Thoracic Oncology

Background:

  • Systemic therapy for malignant mesothelioma has historically offered limited efficacy.
  • Conventional chemotherapies show modest activity, with cisplatin plus pemetrexed being the only combination to demonstrate improved outcomes in a phase III trial.

Purpose of the Study:

  • To survey the current landscape of systemic therapies for mesothelioma.
  • To explore the impact of both conventional and emerging targeted agents in mesothelioma treatment.

Main Methods:

  • Review of existing clinical trial data and literature on mesothelioma systemic therapies.
  • Analysis of the efficacy and impact of conventional chemotherapy and targeted therapy agents.

Main Results:

  • Cisplatin plus pemetrexed is the only combination therapy to show improved clinical outcomes in a phase III trial for mesothelioma.
  • Ongoing clinical investigations are exploring targeted therapies to inhibit critical pathways in mesothelioma.

Conclusions:

  • Systemic treatment options for mesothelioma are currently limited.
  • Further research into targeted therapies holds promise for improving mesothelioma treatment outcomes.

More Related Videos

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...